Kyowa Kirin Co., Ltd. (Japan) holds 0 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 2 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Kyowa Kirin Co., Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/kyowa-kirin-co-ltd

Overview

Kyowa Kirin Co., Ltd. is a leading Japanese pharmaceutical company focused on creating new drugs that address unmet medical needs. It is a subsidiary of Kyowa Hakko Kirin Holdings Co., Ltd. and specializes in therapeutic areas such as oncology, nephrology, and immunology.

Core services & business areas

Pharmaceutical DevelopmentLicensingCommercializationRegulatory Affairs

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Kyowa Kirin Co., Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Kyowa Kirin Co., Ltd. holds 0 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • KW-6356 DRUG SUBSTANCEInactive2014-11-06
  • ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCTInactive2008-05-08
  • OLOPATADINE HYDROCHLORIDE (KW 4679)Inactive1996-01-10

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to Kyowa Kirin Co., Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Kyowa Kirin Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Kyowa Kirin Co., Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.